Related Experiment Video

Updated: May 6, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.4K

Navigating the Challenges of Implementing Tuberculosis Research During COVID-19 Pandemic: Insights from the Pediatric

Aishwarya Venkataraman1, Nancy Hilda Joseph2, Gopika Sadanandan2

  • 1ICMR - National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India. venkataraman.a@icmr.gov.in.

Indian Pediatrics
|May 5, 2026
PubMed

Insights

Pediatric clinical research faces unique challenges, amplified by the COVID-19 pandemic. Addressing ethical and operational issues is crucial for child-centered research during future health crises.

Area of Science:

  • Pediatric clinical research
  • Public health crises
  • Child health

Background:

  • Clinical research with children involves unique physiological, ethical, regulatory, and practical challenges.
  • The COVID-19 pandemic significantly disrupted pediatric research and child health services.
  • The pandemic highlighted ethical, operational, and communication issues in research involving children.

Purpose of the Study:

  • To examine the challenges in pediatric clinical research.
  • To analyze the impact of the COVID-19 pandemic on pediatric research.
  • To identify strategies for strengthening pediatric research in future public health crises.

Main Methods:

  • Review of challenges in pediatric clinical research.
  • Analysis of pandemic-related disruptions to child health services and research.
  • Examination of ethical, operational, and communication tensions.

Main Results:

  • Pediatric research faces inherent complexities.
  • The COVID-19 pandemic exacerbated these challenges, impacting research and child health services.
  • Key issues included informed consent, caregiver trust, and safe research practices.

Conclusions:

  • Understanding these challenges is vital for improving pediatric research.
  • Strengthening research ethics and child-centered approaches is essential.
  • Preparedness is key for maintaining robust pediatric research during future public health emergencies.

Keywords:
Child-friendly research environmentDigital follow-upDigital innovationEthicsPatient safety

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

18.4K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

3.0K

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
1.0K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.8K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
844
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.5K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
438